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Background:  The present study was designed to develop criteria for screening patients with type 2 diabetes mellitus (T2DM) 
for asymptomatic coronary artery disease (CAD).
Methods:  A total of 213 patients with T2DM without typical angina or chest pain were studied between 2002 and 2007. We also 
evaluated 53 patients with T2DM who had reported chest discomfort using an exercise treadmill test (ETT).
Results:  Thirty-one of the 213 asymptomatic patients had positive ETT results. We performed coronary angiography on 23 of 
the 31 patients with a positive ETT and found that 11 of them had significant coronary stenosis. The main differences between 
the patients with significant stenosis and those with a negative ETT were age (63.1±9.4 vs. 53.7±10.1 years, P=0.008) and dura-
tion of diabetes (16.0±7.5 vs. 5.5±5.7 years, P<0.001). The positive predictive value (PPV) of the ETT was calculated to be 47.8%. 
The PPV of the ETT increased to 87.5% in elderly patients (≥60 years) with a long duration of diabetes (≥10 years). The latter 
value is similar to that of patients with T2DM who presented with chest discomfort or exertional dyspnea. The PPV of the ETT 
in symptomatic patients was 76.9%.
Conclusion:  In the interest of cost-effectiveness, screening for asymptomatic CAD could be limited to elderly patients with a 
duration of diabetes ≥10 years. 
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INTRODUCTION
In patients with type 2 diabetes mellitus (T2DM), coronary 
artery disease (CAD) is generally detected at an advanced stage 
with extensive atherosclerosis and poor outcomes, whereas 
CAD is commonly missed in the asymptomatic stage [1]. Dia-
betic patients with asymptomatic CAD have a higher cardiac 
mortality risk than those with symptomatic CAD [2]. In the 
largest autopsy study of diabetic patients without antemortem 
evidence of CAD, approximately 50% of patients under 65 years 
of age and 75% of those 65 years of age and older had high-
grade coronary atherosclerosis [3]. 
  Performing routine screening for asymptomatic CAD in all 
patients with T2DM is debatable for several reasons [4-8]; there-
fore, it is important to adopt appropriate criteria for selecting 
high risk patients who would benefit most from routine CAD 
screening. The CAD screening results may influence a physi-
cian’s lifestyle advice for the patient, treatment targets for gly-
cemia, blood pressure, or cholesterol, or decisions regarding 
the appropriateness of aspirin or angiotensin-converting en-
zyme inhibitor therapy [9]. CAD screening might identify in-
dividuals who could benefit from anti-ischemia therapy (β- 
blocker) or from revascularization, and specifically those with 
left main or severe multivessel disease [4]. 
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  In the present study, which involved asymptomatic patients 
with T2DM, we used the diagnostic approach of performing a 
coronary angiogram following a demonstration of myocardial 
ischemia during an exercise treadmill test (ETT). The present 
study was designed to develop criteria for screening patients 
with T2DM for asymptomatic coronary artery disease.
METHODS
Study patients
A total of 213 outpatients who underwent ETT were enrolled 
from St. Mary’s Hospital Diabetes Clinics (Seoul, Korea) be-
tween March 2002 and November 2007. The exclusion criteria 
were type 1 or secondary diabetes, previous cardiovascular 
disease, typical angina or chest pain, resting electrocardiogram 
(ECG) signs of myocardial ischemia, and severe systemic dis-
ease with a poor prognosis. The diagnosis of T2DM was based 
on American Diabetes Association (ADA) criteria [10]. Pati-
ents with blood pressure over 140/90 mm Hg or those taking 
antihypertensive agents were recorded as being hypertensive 
(HBP). Diabetic nephropathy was defined as the appearance 
of abnormal urinary albumin levels: microalbuminuria (30-
299 mg albumin/24 hr) or macroalbuminuria (>300 mg albu-
min/24 hr). We also analyzed 53 patients with T2DM who un-
derwent an ETT to evaluate their chest discomfort (typical or 
atypical) or exertional dyspnea during the same period.
Protocol for coronary artery disease
The ETT was performed following Bruce protocol. The study 
patients ceased taking beta blockers and calcium channel bloc-
kers 72 hours before the exercise test [11]. A 12-lead ECG was 
used and continuously monitored during the test, and blood 
pressure was recorded at rest and every 2 minutes during exer-
cise and recovery. The ETT was considered positive when a 
horizontal or downsloping ST-segment with a depression ≥1 
mm occurred 0.08 seconds after the J point. The test was con-
sidered equivocal when a ST segment depression<1 mm was 
observed, or when a left bundle branch block or premature 
ventricular beats >6 beats/min were seen. The test was consid-
ered inconclusive if the patient failed to reach 85% of the pre-
dicted maximal heart rate for his or her age. All subjects with a 
positive screening test underwent cardiology consultation. 
  Coronary angiography was performed only when the ETT 
was positive. We defined asymptomatic CAD as objective evi-
dence of ischemia occurring in an asymptomatic patient dur-
ing the ETT. We also defined flow-limiting CAD as a stenosis 
of more than 70% on coronary angiography. Coronary artery 
stenosis greater than 70% compared to pre-stenotic measure-
ments was considered significant for CAD.
Assays
All blood samples were taken in the morning following a min-
imum 8-hour fast. Glycated hemoglobin (A1C) levels were de-
termined by high-performance liquid chromatography (HLC-
723 G7; Tosoh Co., Tokyo, Japan). Total cholesterol, triglycer-
ides, and high density lipoprotein cholesterol (HDL-C) were 
determined using commercial kits. 
Statistical analysis
All data were analyzed using SPSS version 10.0 for Windows 
statistical software (SPSS Inc., Chicago, IL, USA). The data are 
presented as mean±standard deviation, unless otherwise stated. 
  Patient characteristics were compared by presence or ab-
sence of symptoms using independent sample Student’s t-tests 
for continuous measures and χ2 tests for categorical measures. 
Com  parisons of the clinical and biochemical characteristics 
among the groups were made using ANOVA and post hoc 
analysis (Tukey test). P values <0.05 were considered statisti-
cally significant.
RESULTS
Clinical characteristics
The baseline clinical characteristics of all asymptomatic and 
Table 1. Baseline clinical and laboratory characteristics 
Asymptomatic 
(n=213)
Symptomatic
(n=53)
P value
Age, yr 55.3±10.2 56.7±10.0 0.300
Sex, M/F 167/46 28/25  < 0.001
Duration of diabetes, yr 6.4±6.5     10.3±8.9 0.004
BMI, kg/m
2      24.7±2.6     24.7±2.8 0.873
A1C, % 6.7±1.1 7.2±1.1 0.010
Total cholesterol, mmol/L 4.6±0.9 4.8±1.0 0.130
Triglyceride, mmol/L 1.7±1.1 1.7±1.3 0.536
HDL-C, mmol/L 1.1±0.3 1.1±0.3 0.821
HBP, % 46.4 58.5 0.063
Nephropathy, % 22.5 42.5 0.005
BMI, body mass index; HDL-C, high density lipoprotein cholesterol; 
HBP, high blood pressure.Kim MK, et al.
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symptomatic patients are summarized in Table 1. The mean 
duration of diabetes was significantly longer in symptomatic 
patients versus those without symptoms (10.3±8.9 years vs. 
6.4±6.5 years, P=0.004). The symptomatic patients had higher 
A1C levels (7.2±1.1% vs. 6.7±1.1%, P=0.010) and a greater 
prevalence of HBP (58.5% vs. 46.4%, P=0.063) and nephropa-
thy (42.5% vs. 22.5%, P=0.005). 
Flowchart of asymptomatic patients who underwent the 
ETT
Fig. 1 shows the flowchart for patients who underwent an ETT. 
Eighteen patients (8.5%) were unable to complete the ETT; 
nine due to leg discomfort, five due to fatigue, three due to dys-
pnea, and one due to dizziness. Nine of the 195 completed tests 
were not considered diagnostic because either the upsloping 
ST segment depression or the horizontal ST segment depres-
sion was less than 1 mm. The remaining 186 completed tests 
provided data suitable for diagnosis and were subdivided into 
those having a positive ETT (n=31, 16.6%) and those having a 
negative ETT (n=155, 83.3%). All subjects with a positive 
screening test underwent cardiology consultation. Among the 
31 patients with a positive treadmill test, two had no defects 
on the thallium scan and six patients refused further evalua-
tion. The remaining 23 patients underwent coronary angiog-
raphy. Coronary angiography revealed coronary stenosis ≥70% 
in eleven patients: three patients had one diseased vessel, sev-
en had two diseased vessels, and one had three diseased vessels. 
Of the remaining twelve patients, one presented with a 50-70% 
lumen reduction and eleven had either a lumen reduction of 
<50% or no lumen reduction. The positive predictive value 
(PPV) for the ETT was calculated to be 47.8% (37.5% for men 
and 71% for women) (Fig. 2).
Comparison of patient characteristics according to the 
results of the ETT and coronary angiography
We divided the 213 patients into three groups. One group had 
negative ETT results (Group A). The second group had a posi-
tive ETT, but negative coronary angiography (Group B). This 
second group, therefore, had only a positive functional test. 
The third group had a positive ETT and positive coronary an-
giography, indicative of flow-limiting coronary artery disease 
(Group C). 
  Table 2 shows a comparison of the differences in variables 
for the three groups by ANOVA. The main differences between 
the 11 patients who presented with coronary lesions (Group 
C) and the 155 patients with a negative ETT (Group A) were 
age (63.1±9.4 years vs. 53.7±10.1 years, P=0.008) and dura-
tion of diabetes (16.0±7.5 years vs. 5.5±5.7 years, P<0.001). 
18 (8.5%) Were unable to complete the test
9 Were not diagnostic test
31 (16.6%) Were positive test 155 (83.3%) Were negative test
213 Underwent exercise treadmill test
195 (91.5%) Were able to complete the test
186 Were diagnostic test
Fig. 1. Flowchart of patients who underwent the exercise treadmill test. 
Fig. 2. Positive predictive values (PPV) of an exercise treadmill 
test (ETT) for coronary artery stenosis. DM, diabetes mellitus.
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Serum A1C levels and lipid profiles were not significantly dif-
ferent among the three groups. 
ETT in elderly patients (≥60 years) with a long duration of 
diabetes (≥10 years)
We determined that the main factors influencing the results of 
the ETT and coronary angiography were age and duration of 
diabetes. We arbitrarily selected an age of 60 years and a 10-
year duration of diabetes as cut-off points. We examined how 
the results might change if the elderly patients with a long du-
ration of diabetes underwent only an ETT. Fig. 3 shows the 
flowchart for the 29 elderly study patients with a long duration 
of diabetes who underwent only the ETT. Of these 29 patients 
who underwent an ETT, 4 (13.7%) were unable to complete 
the ETT. In addition, 2 of the 25 completed tests were not con-
sidered diagnostic, and the remaining 23 tests were considered 
suitable for diagnosis. Of the 23 suitable tests, almost half of 
them (n=10, 43.4%) had a positive ETT. Eight of the ten pa-
tients who had a positive ETT underwent coronary angiogra-
phy, and 7 of the 8 had coronary stenosis greater than 70%. In 
this segment of our study population, the PPV using the ETT 
was 87.5% (Fig. 2).
ETT results for patients who presented with chest 
discomfort or exertional dyspnea
We analyzed 53 study patients who underwent the ETT to 
evaluate their (typical or atypical) chest discomfort or exer-
tional dyspnea. Among them, 9 patients (16.9%) were unable 
to complete the ETT. Four of the 44 completed tests were not 
considered diagnostic and the remaining 40 patients’ tests were 
considered suitable for diagnosis. Seventeen patients (42.5%) 
had a positive ETT. Thirteen of the seventeen patients under-
went coronary angiography and ten of the thirteen patients 
(three patients with one diseased vessel, four with two diseased 
Table 2. Clinical and laboratory characteristics by exercise 
tread  mill test and coronary angiography results
Group A
(n=155)
Group B
(n=12)
Group C
(n=11)
P 
value
a
Age, yr 53.7±10.1 54.9±7.2 63.1±9.4 0.008 
Sex, M/F 125/30 10/2 6/5 0.054
Duration of diabetes, yr 5.5±5.7 7.7±8.1 16.0±7.5 <0.001 
BMI, kg/m
2  24.7±2.6 25.6±3.3 24.4±2.4 0.947
A1C, % 6.6±1.2 6.4±0.7   7.0±0.8 0.112
Total cholesterol, 
  mmol/L
4.6±0.9 4.7±0.8   4.5±0.9 0.548
Triglyceride, mmol/L 1.7±1.2 1.9±1.1   1.5±0.6 0.231
HDL-C, mmol/L 1.1±0.3 0.9±0.1   1.0±0.3 0.575
HBP, %     45.8     41.6 63.6 0.101
Nephropathy, % 20 20 37.5 0.223
Group A, negative ETT; Group B, positive ETT & negative CAG; 
Group C, positive ETT & positive CAG.
ETT, exercise treadmill test; CAG, coronary angiography; BMI, body 
mass index; HDL-C, high density lipoprotein cholesterol; HBP, high 
blood pressure.
aGroup A vs. Group C.
Fig. 3. Flowchart of elderly patients (≥60 years) with a long duration of diabetes (≥10 years). CAG, coronary angiography.
2 Were not diagnostic test
4 (13.7%) Were unable to complete the test
29  Underwent exercise treadmill test
25 (86.2%) Were able to complete the test
23 Were diagnostic test
13 (56.5%) Were negative test 10 (43.4%) Were positive test
8 Underwent CAG
7  Were angiographic stenosis 1 Was normal CAG
2 Refused further evaluationKim MK, et al.
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vessels, and three with three diseased vessels) had coronary 
stenosis greater than 70%. In this study population, the PPV 
using the ETT was calculated to be 76.9% (Fig. 2).
 
DISCUSSION
We found the main differences between the asymptomatic pa-
tients with significant coronary stenosis and those with nega-
tive ETT to be duration of diabetes and age. The PPV of the 
ETT for predicting angiographic coronary disease was 48%. 
This value was found to be higher when the patients were el-
derly (≥60 years) and had a long duration of diabetes (≥10 
years), or were symptomatic. To improve cost-effectiveness, 
screening for asymptomatic CAD could be limited to elderly 
patients with a duration of diabetes of 10 years or more. 
  As previously reported, even when a satisfactory ETT test is 
completed, the PPV in detecting silent coronary stenosis is low, 
between 40 and 60% [8,12,13]. In our study, the PPV of the 
ETT increased to 88% in elderly patients with a long duration 
of diabetes. This value was similar to that of type 2 diabetes 
mellitus patients who presented with chest discomfort or exer-
tional dyspnea: the PPV of the ETT in symptomatic patients 
was 76.9%. 
  The ETT is often not feasible for diabetic patients because 
their exercise capability may be impaired by peripheral vascu-
lar or neuropathic disease [14]. In our study, 18 patients (8.5%) 
were unable to complete the ETT, mostly due to leg discom-
fort or dyspnea. A completely normal ETT has been reported 
to be a marker for a good prognosis in patients with diabetes 
[14]. Compared with such imaging procedures as coronary 
computed tomography (CT), echocardiography, and stress 
single photon emission computed tomography myocardial per-
fusion imaging, the treadmill exercise test can be performed at 
a much lower cost. The ETT is preferable to a pharmacological 
stress test because it depicts the heart’s actual workload and 
better simulates everyday cardiac strain [15]. Furthermore, 
patients are not exposed to ionizing radiation and contrast. 
Therefore, initially performing an ETT in patients who are able 
to exercise is recommended. The more recently developed non-
invasive, multi-slice CT angiography is recommended for ex-
clusion of coronary heart disease, but has the associated disad-
vantages of high radiation exposure and cost [14]. An estimat-
ed 1 in 270 women who underwent CT coronary angiography 
at age 40 will develop cancer from that CT scan, compared with 
an estimated 1 in 8,100 women who had a routine head CT scan 
at the same age [16]. For these reasons, we chose the ETT as a 
screening tool for coronary artery disease in asymptomatic 
patients with T2DM. Further studies will guide us with respect 
to which modality is most appropriate. 
  The 1998 ADA Consensus Development Conference on the 
diagnosis of coronary artery disease in people with diabetes 
recommended performing stress screening for coronary ar-
tery disease in asymptomatic patients with ≥2 cardiovascular 
risk factors (smoking, arterial hypertension, hypercholesterol-
emia, family history of premature CAD, microalbuminuria) 
[17]. Unfortunately, recent studies have shown that the pres-
ence of traditional categorical risk factors did not help to iden-
tify asymptomatic patients with a higher prevalence of coro-
nary artery disease [18]. In the absence of symptomatic CAD, 
clinical features that help to identify patients with an increased 
risk for myocardial infarction or cardiac death include evidence 
of other atherosclerotic vascular disease, microalbuminuria 
and chronic kidney disease, autonomic neuropathy, retinopa-
thy, hyperglycemia, abnormal resting ECGs, age, sex, and both 
traditional and novel cardiac risk factors [5]. However, the rou-
tine screening of asymptomatic patients with T2DM and nor-
mal ECGs remains controversial [19]. In our study, patients 
with significant coronary stenosis tended to have higher A1C 
levels and to have a greater prevalence of HBP and nephropa-
thy, however, the difference was not statistically significant (Hb-
A1C, 7.0% vs. 6.6%; HBP, 63.6% vs. 45.8%; Nephropathy, 37.5% 
vs. 20%). The size of our study population may have been too 
small to draw conclusions about the other covariates studied. 
  We found the main differences between the asymptomatic 
patients with significant coronary stenosis and those with a 
negative ETT were the duration of diabetes and age. It is well 
known that age is a strong predictor of CAD [5], however, du-
ration of diabetes is not included among CAD predictors in 
the ADA recommendations [5]. Debate on the relationship 
between duration of diabetes and CAD continues, and several 
recent studies have reported a positive correlation [8,20]. 
  Our study has several limitations. First, it used a retrospec-
tive design, which is prone to selection bias. Second, data on 
other traditional cardiovascular risk factors, such as smoking, 
family history of premature CAD, autonomic neuropathy and 
retinopathy were not available. Third, clinical features such as 
chronic kidney disease, hyperglycemia, and hypertension did 
not differ between the groups. The small number of subjects in 
our study may also be a limitation. 
  In conclusion, we recommend screening for coronary ar-Silent myocardial ischemia in type 2 diabetic patients
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tery disease in elderly patients (≥60 years) with a duration of 
diabetes ≥10 years. Further studies are needed to evaluate the 
effectiveness of routine screening for asymptomatic CAD in 
this patient subgroup.
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